GeoVax Labs Inc (GOVX) Stock Analysis

GeoVax Labs Inc (GOVX) is a publicly traded company in the HEALTHCARE sector. It trades at $2.10, carries a market capitalization of $11.52M. This page summarizes the public market data, fundamentals, and frequently asked questions for GOVX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.10
• Market Cap: $11.52M
• EPS: $-13.82
• 52-Week High: $34.75
• 52-Week Low: $0.96

Market Sentiment

GeoVax Labs Inc currently has a Bullish sentiment score of 0.45.

About GeoVax Labs Inc

GeoVax Labs, Inc. is a clinical-stage biotechnology company headquartered in Smyrna, Georgia, dedicated to the development of pioneering vaccines and immunotherapies for infectious diseases and cancers. Utilizing a proprietary modified vaccinia Ankara virus-like particle platform, the company is advancing its innovative pipeline of therapeutic candidates through multiple clinical trial stages. GeoVax's focus on addressing critical unmet medical needs and its commitment to cutting-edge vaccine...

GNG Research Analysis

GNG Research scores GeoVax Labs Inc (GOVX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GOVX.

Frequently Asked Questions

Does GOVX pay dividends?

GeoVax Labs Inc (GOVX) does not currently pay a regular dividend.

What is GOVX's market cap?

GeoVax Labs Inc (GOVX) has a market capitalization of $11.52M with a current stock price of $2.10.